DUAL INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AND mTOR AS A NEW THERAPEUTIC OPTION FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)

被引：0
|
作者：
Chiarini, F. [1 ]
Grimaldi, C. [1 ]
Tazzari, P. L. [2 ]
Ricci, F. [2 ]
Pagliaro, P. [2 ]
Martelli, A. M. [1 ]
机构：
[1] Univ Bologna, Dipartimento Sci Anat Umane, I-40126 Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, Bologna, Italy
来源：
CYTOMETRY PART A | 2010年 / 77A卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
    Hiroo Katsuya
    Lucy B. M. Cook
    Aileen G. Rowan
    Yorifumi Satou
    Graham P. Taylor
    Charles R. M. Bangham
    Biomarker Research, 6
  • [32] Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
    Katsuya, Hiroo
    Cook, Lucy B. M.
    Rowan, Aileen G.
    Satou, Yorifumi
    Taylor, Graham P.
    Bangham, Charles R. M.
    BIOMARKER RESEARCH, 2018, 6
  • [33] Complex Karyotype with ≥3 Cytogenetic Alterations is a New Marker of Worse Prognosis in Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Genesca, Eulalia
    Morgades, Mireia
    Gonzalez-Gil, Celia
    Fuster-Tormo, Francisco
    Haferlach, Claudia
    Meggendorfer, Manja
    Montesinos, Pau
    Barba, Pere
    Gil, Cristina
    Coll, Rosa
    Jose Moreno, Maria
    Martinez-Carballeira, Daniel
    Garcia-Cadenas, Irene
    Vives, Susana
    Ribera, Jordi
    Gonzalez-Campos, Jose
    Diaz-Beya, Marina
    Mercadal, Santiago
    Artola, Teresa
    Cladera, Antonia
    Tormo, Mar
    Bermudez, Arancha
    Vall-Llovera, Ferran
    Martinez-Sanchez, Pilar
    Amigo, Mari-Luz
    Monsalvo, Silvia
    Novo, Andres
    Cervera, Marta
    Garcia-Grinon, Antonio
    Ciudad, Juana
    Cervera, Jose
    Hernandez-Rivas, Jesus-Maria
    Granada, Isabel
    Haferlach, Torsten
    Orfao, Alberto
    Sole, Francesc
    Maria Ribera, Josep
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S167 - S168
  • [34] Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
    Evangelisti, Camilla
    Chiarini, Francesca
    McCubrey, James A.
    Martelli, Alberto M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
  • [35] PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas
    Martin-Sanchez, Esperanza
    Rodriguez-Pinilla, Socorro M.
    Lombardia, Luis
    Dominguez-Gonzalez, Beatriz
    Sanchez-Beato, Margarita
    Romero, Diana
    Wozniak, Magdalena B.
    Mollejo, Manuela
    Alves, Javier
    Luis Rodriguez-Peralto, Jose
    Menarguez, Javier
    Cigudosa, Juan C.
    Ortiz-Romero, Pablo L.
    Garcia, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    BLOOD, 2011, 118 (21) : 1490 - 1491
  • [36] Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia
    Laukkanen, Saara
    Veloso, Alexandra
    Yan, Chuan
    Oksa, Laura
    Alpert, Eric J.
    Do, Daniel
    Hyvarinen, Noora
    McCarthy, Karin
    Adhikari, Abhinav
    Yang, Qiqi
    Iyer, Sowmya
    Garcia, Sara P.
    Pello, Annukka
    Ruokoranta, Tanja
    Moisio, Sanni
    Adhikari, Sadiksha
    Yoder, Jeffrey A.
    Gallagher, Kayleigh
    Whelton, Lauren
    Allen, James R.
    Jin, Alex H.
    Loontiens, Siebe
    Heinaniemi, Merja
    Kelliher, Michelle
    Heckman, Caroline A.
    Lohi, Olli
    Langenau, David M.
    BLOOD, 2022, 140 (17) : 1891 - 1906
  • [37] Anticancer effects of 3,3′-diindolylmethane (DIM) in multiple T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) cell lines
    Benninghoff, Abby D.
    Hagman, Amanda M.
    Shorey, Lyndsey E.
    Williams, David E.
    CANCER RESEARCH, 2012, 72
  • [38] Targeting the MYC and PI3K Pathways Eliminates Leukemia-Initiating Cells in T-cell Acute Lymphoblastic Leukemia
    Schubbert, Suzanne
    Cardenas, Anjelica
    Chen, Harrison
    Garcia, Consuelo
    Guo, Wei
    Bradner, James
    Wu, Hong
    CANCER RESEARCH, 2014, 74 (23) : 7048 - 7059
  • [39] Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia
    Alameen, Ayman A. M.
    Simioni, Carolina
    Martelli, Alberto M.
    Zauli, Giorgio
    Ultimo, Simona
    McCubrey, James A.
    Gonelli, Arianna
    Marisi, Giorgia
    Ulivi, Paola
    Capitani, Silvano
    Neri, Luca M.
    ONCOTARGET, 2016, 7 (34) : 55690 - 55703
  • [40] Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death
    Tosello, Valeria
    Saccomani, Valentina
    Yu, Jiyang
    Bordin, Fulvio
    Amadori, Alberto
    Piovan, Erich
    ONCOTARGET, 2016, 7 (29) : 45715 - 45729
12345